{"id":28663,"date":"2006-06-01T00:00:00","date_gmt":"2006-06-01T00:00:00","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/los-preparados-comerciales-de-albumina-humana-de-uso-clinico-son-inmunosupresores-in-vitro\/"},"modified":"2024-06-06T17:51:14","modified_gmt":"2024-06-06T17:51:14","slug":"los-preparados-comerciales-de-albumina-humana-de-uso-clinico-son-inmunosupresores-in-vitro","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/los-preparados-comerciales-de-albumina-humana-de-uso-clinico-son-inmunosupresores-in-vitro\/","title":{"rendered":"Los preparados comerciales de alb\u00famina humana de uso cl\u00ednico son inmunosupresores in vitro."},"content":{"rendered":"\n<p><span style=\"font-size: 8pt; font-family: Arial;\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Bar%2DOr+D%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Bar-Or D<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Thomas+GW%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Thomas GW<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Bar%2DOr+R%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Bar-Or R<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Rael+LT%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Rael LT<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Scarborough+K%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Scarborough K<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Rao+N%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Rao N<\/span>\n<\/a>, <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&amp;cmd=Search&amp;itool=pubmed_Abstract&amp;term=%22Shimonkevitz+R%22%5BAuthor%5D\">\n  <span style=\"color: windowtext;\">Shimonkevitz R<\/span>\n<\/a>. <span style=\"color: windowtext;\">Crit Care Med.<\/span> 2006 Jun;34(6):1707-12.<\/span><\/p>\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Bar-Or D , Thomas GW , Bar-Or R , Rael LT , Scarborough K , Rao N , Shimonkevitz R . Crit Care Med. 2006 Jun;34(6):1707-12.<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[310],"tags":[],"class_list":["post-28663","resources","type-resources","status-publish","hentry","category-otros-riesgos-y-peligros-de-la-transfusion"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/28663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=28663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=28663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=28663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}